The third phase of clinical trials of the Cuban “Abdala” vaccine, which is anti-coronavirus, showed its 100% efficacy against severe cases of Covid disease.
The results of clinical trials published by Prensa Latina Agency, citing Martha Ayala, director of the Center for Genetic Engineering and Biotechnology that designed the vaccine, place the Abdala vaccine among the most effective “Covid-19” vaccines in the world.
“Data on the effectiveness of the vaccine has already been obtained in the third phase of clinical trials, and these results are excellent,” Ayala said.
Several websites stated that the name of the vaccine was derived from “Abdullah’s play” written by the famous Cuban poet Jose Marti, who died in 1895 at the age of 42, and who is known for his penchant for Arabs and glorifying them in many of his poems, to the point where he made most of the heroes of his poems among them, as the hero of the poetic play he composed. In his youth, he made an Egyptian young man from Nubia his hero, and his name was Abdullah.
Ayala added that it was decided to increase the number of participants in the test group, to 300,000 people.
The Cuban government has set a goal of vaccinating 70 percent of the country’s 11.2 million population by next August, with everyone vaccinated before the end of the year.
Earlier, the State Center for the Control of Medicines, Equipment and Medical Devices (CECMED) in Cuba, authorized the emergency use of the Abdala vaccine.
In the second half of June, Cuba announced the completion of clinical trials of the vaccine, and its effectiveness against the transmission of symptoms of the Coronavirus was 92.28%.
Abdala vaccine is based on Protein Subunit technology. Subunit vaccines include only the parts of the virus that best stimulate the immune system.
This type of “Covid-19” vaccine contains harmless “spike” proteins, and once the immune system recognizes them, it makes antibodies and defensive white blood cells.